IHE

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $-1.8M ExitQ1 2026 $1.8M -- $91.87
Ken FisherFisher Asset Management $240M2.8M shares AddQ1 2026 $175k $86.68 $91.87
Ken FisherFisher Asset Management $240M2.8M shares AddQ4 2025 $30M $84.83 $91.87
Ken GriffinCitadel Advisors $1.8M21.4k shares AddQ4 2025 $1.3M $84.83 $91.87
Ken FisherFisher Asset Management $14.3M AddQ3 2025 $14M -- $91.87
Ken GriffinCitadel Advisors $-2.0M TrimQ3 2025 $2.0M -- $91.87

News

fool.comIs iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?fool.comJun 17

etftrends.comHealthcare ETFs: From Broad Exposure to Big Breakthroughsetftrends.comJun 11

fool.comiShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returnsfool.comJun 10

zacks.comInside the GLP-1 Boom: ETF Picks for the Obesity Drug Marketzacks.comJun 10

zacks.comMiddle East Erupts Again: Buy these Healthcare ETFs Before the Next Strikezacks.comJun 9

Trade IHE

About iShares U.S. Pharmaceuticals ETF

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.

IPO Date: May 5, 2006

Market Data

Open: $93.39
High: $93.39
Low: $90.86
Volume: 168.5K
Avg Volume: 96.2K
52W High: $95.60
52W Low: $64.46

Valuation

Market Cap: $712M
Dividend Yield: 1.47%

Financials

Financial statement snapshot is not available yet.

Events

DividendJun 15

$0.2848